Crinetics Pharmaceuticals (CRNX) Inventory (2025 - 2026)

Crinetics Pharmaceuticals' (CRNX) quarterly Inventory came in at $3.1 million in Q1 2026, up 51.53% quarter-over-quarter from $2.0 million in Q4 2025.

Crinetics Pharmaceuticals (CRNX) Inventory (2025 - 2026) Analysis & Trends

Crinetics Pharmaceuticals' Inventory history runs 2 years deep, the most recent figure standing at $3.1 million for Q1 2026.

  • On a quarterly basis, Inventory changed N/A year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $3.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.0 million, changed N/A from the prior year.
  • Inventory climbed to $3.1 million in Q1 2026 per CRNX's latest filing, from $2.0 million in the prior quarter.
  • Across five years, Inventory topped out at $3.1 million in Q1 2026 and bottomed at $2.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 681.59 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.77 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.10 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 371.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Crinetics Pharmaceuticals 8.71 Bn 8.71 Bn 10.53 Mn 3.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.06 Mn
Dec 31, 2025 2.02 Mn